Transient angiotensin-converting enzyme inhibition confers sex-specific protection against angiotensin II-induced cardiac remodeling
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00753.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Alexandra M Garvin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, Arizona, United States. Hauptthemen laut MEDLINE: Angiotensin II, Angiotensin-Converting Enzyme Inhibitors, Ventricular Remodeling, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), NIGMS NIH HHS.
Abstract (Originalsprache)
Here, we determine, for the first time that female spontaneously hypertensive rats are responsive to transient angiotensin-converting enzyme inhibitor (ACEi) treatment. Prior work showed that transient ACEi treatment induced persistent protection against a future stimulus in males. Here, Ang II-induced cardiac fibrosis was attenuated by transient ACEi treatment in both sexes. Notably, the underlying mechanism of action is sex-dependent. Specifically, changes in collagen deposition in male but not female hearts correlate with collagen gene expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, Arizona, United States.
- Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, United States.
- School of Graduate Studies, Meharry Medical College, Nashville, Tennessee, United States.
- Research Service, Nashville VA Medical Center, Nashville, Tennessee, United States.
- Department of Health and Kinesiology, Purdue University, West Lafayette, Indiana, United States.
ORCID-Profile: Alexandra M Garvin, Merry L Lindsey, Chad C Carroll, Taben M Hale
Förderung
- NHLBI NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- NIGMS NIH HHS
- U.S. Department of Veterans Affairs (VA)
- BLRD VA
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
Zitieren
APA
Garvin, A. M., Floyd, D. B., Bailey, A. C., Lindsey, M. L., Carroll, C. C., & Hale, T. M. (2025). Transient angiotensin-converting enzyme inhibition confers sex-specific protection against angiotensin II-induced cardiac remodeling. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00753.2024
Vancouver
Garvin AM, Floyd DB, Bailey AC, Lindsey ML, Carroll CC, Hale TM. Transient angiotensin-converting enzyme inhibition confers sex-specific protection against angiotensin II-induced cardiac remodeling. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00753.2024
BibTeX
@article{Garvin2025,
author = {Garvin, Alexandra M and Floyd, Dana B and Bailey, Alexis C and Lindsey, Merry L and Carroll, Chad C and Hale, Taben M},
title = {Transient angiotensin-converting enzyme inhibition confers sex-specific protection against angiotensin II-induced cardiac remodeling},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00753.2024}
}
EUVIMED